Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Change in Cash (2016 - 2025)

Historic Change in Cash for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to -$83.4 million.

  • Rhythm Pharmaceuticals' Change in Cash rose 2696.66% to -$83.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 12813.79%. This contributed to the annual value of $29.2 million for FY2024, which is 14318.6% up from last year.
  • Per Rhythm Pharmaceuticals' latest filing, its Change in Cash stood at -$83.4 million for Q3 2025, which was up 2696.66% from $29.6 million recorded in Q2 2025.
  • Over the past 5 years, Rhythm Pharmaceuticals' Change in Cash peaked at $108.2 million during Q2 2024, and registered a low of -$114.1 million during Q3 2024.
  • In the last 5 years, Rhythm Pharmaceuticals' Change in Cash had a median value of -$4.5 million in 2023 and averaged -$2.6 million.
  • Its Change in Cash has fluctuated over the past 5 years, first crashed by 19340.04% in 2023, then soared by 169711.11% in 2024.
  • Rhythm Pharmaceuticals' Change in Cash (Quarter) stood at -$33.1 million in 2021, then tumbled by 73.32% to -$57.4 million in 2022, then skyrocketed by 92.14% to -$4.5 million in 2023, then skyrocketed by 1022.38% to $41.6 million in 2024, then crashed by 300.31% to -$83.4 million in 2025.
  • Its Change in Cash stands at -$83.4 million for Q3 2025, versus $29.6 million for Q2 2025 and $17.0 million for Q1 2025.